Article
Lower cognitive performance in healthy G2019S LRRK2 mutation carriers.
Neurology - 4 Sept 2012
Thaler Avner, Mirelman Anat, Gurevich Tanya, Simon Ely, Orr-Urtreger Avi, Marder Karen, Bressman Susan, Giladi Nir
Abstract excerpt
OBJECTIVE: To assess cognitive abilities of healthy first-degree relatives of Ashkenazi patients with Parkinson disease (PD), carriers of the G2019S mutation in the LRRK2 gene. METHODS: In this observational study, 60 consecutive healthy first-degree relatives (aged 50.9 ± 6.2 years; 48% male; 30 G2019S carriers) were assessed using a computerized cognitive program, the Montreal Cognitive Assessment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
